OTC Cough, Cold, and Allergy Medicine Market Revenue in the APEJ Region will Grow 1.3 Times by 2031 End

Key Segments in OTC Cough, Cold, and Allergy Medicine Industry Research

• Drug Type

  • OTC Antihistamine
  • OTC Expectorants
  • OTC Bronchodialators
  • OTC Antibiotics

• OTC Channel

  • Sales of OTC Cough, Cold & Allergy Medicines via Pharmacies
  • Drug Store Sales of OTC Cough, Cold & Allergy Medicines
  • Modern Trade Sales of OTC Cough, Cold & Allergy Medicines
  • Online Sales of OTC Cough, Cold & Allergy Medicines

• Dosage

  • OTC Cough, Cold & Allergy Medicine Capsules
  • OTC Cough, Cold & Allergy Medicine Liquid
  • OTC Cough, Cold & Allergy Medicine Tablets
  • OTC Cough, Cold & Allergy Medicine Lozenges
  • Others
    • OTC Liquid Cough, Cold & Allergy Solutions
    • OTC Liquid Cough, Cold & Allergy Drops
    • OTC Liquid Cough, Cold & Allergy Granules
    • OTC Liquid Cough, Cold & Allergy Syrup
    • OTC Liquid Cough, Cold & Allergy Pills

• Application

  • OTC Cough, Cold & Allergy Medicines for Babies
  • OTC Cough, Cold & Allergy Medicines for Adults
  • OTC Cough, Cold & Allergy Medicines for School-age Children

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=71

OTC Cough, Cold, and Allergy Medicine Market: Report Scope

A recent study by Fact.MR on the OTC cough, cold, and allergy medicine market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates recent market developments, strategic market growth analysis, market size, category market growths, product approvals, product launches, geographical expansions, and technological innovations associated with OTC cough, cold, and allergy medicines.

The study also provides the dynamics responsible for influencing the future status of the market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies manufacturing OTC cough, cold, and allergy medicines, along with their product portfolios, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of OTC cough, cold, and allergy medicines across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account sales of OTC cough, cold, and allergy medicines during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).

Market estimates at global and regional levels for OTC cough, cold, and allergy medicine is available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global OTC cough, cold, and allergy medicine market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the OTC cough, cold, and allergy medicine market during the forecast period.

Country-specific valuation on demand for OTC cough, cold, and allergy medicines has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value and volume for emerging countries has also been included in the report.

Competition Analysis

The report sheds light on leading manufacturers of OTC cough, cold, and allergy medicines, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering OTC cough, cold, and allergy medicine has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the OTC cough, cold, and allergy medicine market.

Following insights from Fact.MR’s global OTC cough, cold and allergy market will be important for market’s future growth

• The OTC cough, cold and allergy medicines market in Asia Pacific excluding Japan (APEJ) is anticipated to remain highly attractive throughout the assessment period. In 2017 and beyond, the region is projected to command for a noteworthy revenue share of the global market. This is primarily owing to dropping air quality and increase pollution that is resulting in higher occurrence of respiratory ailments.  In addition, rapid adoption of OTC medicines owing to their convenience of purchase and cost-efficiency is facilitating the growth of the market in the region.
• On the basis of drug type, antihistamine is anticipated to command for over one-third revenues share of the market by the end of 2017.  Antihistamines drugs help in restricting the histamine release from histamine-1 receptors, moreover these drugs can effectively treat watery eyes or runny nose, inflammation (redness), sneezing and swelling (edema).
• By OCT channel, pharmacies will continue to be the top OCT channel for sales of allergy, cold and cough drugs between 2017 and 2022. During the same time, the drug store segment is projected to retain its second spot.
• Based on dosage, the tablet segment is projected to command for a significant share of the market in terms of revenue and is likely to reach a valuation of nearly US$ 12,425 Mn over 2022.